Additional file 1: Table S1. of Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration

Peeters, Olivier; Ferry, Tristan; Ader, Florence; Boibieux, André; Braun, Evelyne; Bouaziz, Anissa; Karsenty, Judith; Forestier, Emmanuel; Laurent, Frédéric; Lustig, Sébastien; Chidiac, Christian; Valour, Florent

doi:10.6084/m9.figshare.c.3624233_D1.v1

12879_2016_1955_MOESM1_ESM.docx (19.97 kB)

Additional file 1: Table S1. of Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration

journal contribution

posted on 2016-11-03, 05:00 authored by Olivier Peeters, Tristan Ferry, Florence Ader, André Boibieux, Evelyne Braun, Anissa Bouaziz, Judith Karsenty, Emmanuel Forestier, Frédéric Laurent, Sébastien Lustig, Christian Chidiac, Florent Valour

Comparison of patients presenting or not a teicoplanin overdose (teicoplanin plasmatic trough concentration > 25 mg/L) and reaching or not the therapeutic concentration of 15 mg/L during the first 14 days of treatment (DOCX 19 kb)